{
    "data": [
        {
            "id": "6904c487ecb8a700014607a8",
            "title": "If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">IDEXX Laboratories (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/IDXX\" target=\"_blank\">IDXX</a>) has outperformed the market over the past 10 years by 12.0% on an annualized basis producing an average annual return of 24.51%. Currently, IDEXX Laboratories has a market capitalization of $51.31 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $100 In IDXX:</strong> If an investor had bought $100 of IDXX stock 10 years ago, it would be worth <strong>$899.08</strong> today based on a price of $633.13 for IDXX at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">IDEXX Laboratories's Performance Over Last 10 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761920136_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761920136_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761920136_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48560942/if-you-invested-100-in-idexx-laboratories-stock-10-years-ago-you-would-have-this-much-today",
            "pub_date": "2025-10-31 22:15:39",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904c61aecb8a70001460894",
            "title": "Charter&#39;s Q3 Miss Sends Stock Lower As Internet, Video Losses Pile Up",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Charter Communications Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CHTR\" target=\"_blank\">CHTR</a>) stock dropped after it reported downbeat <a href=\"https://www.benzinga.com/pressreleases/25/10/n48554138/charter-announces-third-quarter-2025-results\" rel=\"noreferrer noopener\" target=\"_blank\">fiscal third-quarter</a> 2025 results Friday.</p><!--/$--><!--$--><p class=\"block core-block\">The company clocked a quarterly revenue decline of 0.9% year-on-year to $13.67 billion, missing the <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">analyst consensus estimate</a> of $13.74 billion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">EPS of $8.34 missed the analyst consensus estimate of $9.37.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/markets/earnings/25/07/46629864/charter-stock-slides-despite-revenue-beat-mobile-gains-offset-by-internet-video-subscriber-losses\" rel=\"noreferrer noopener\" target=\"_blank\">Charter Stock Slides Despite Revenue Beat—Mobile Gains Offset By Internet, Video Subscriber Losses</a></em></strong></p><!--/$--><!--$--><p class=\"block core-block\">The topline performance reflects lower residential video and advertising sales revenues.</p><!--/$--><!--$--><div class=\"sc-gQfuga iaHpuj\"></div><!--/$--><!--$--><p class=\"block core-block\">Charter lost 109,000 internet customers compared to a decline of 110,000 in the year-ago period, which included the impact of disconnects related to the end of the FCC’s Affordable Connectivity Program in the third quarter of 2024.</p><!--/$--><!--$--><p class=\"block core-block\">Charter’s residential video customers decreased by 70,000 compared to 294,000 in the previous year as streaming companies like <strong>Netflix </strong>gain traction.</p><!--/$--><!--$--><p class=\"block core-block\">Charter’s total mobile lines increased by 493,000 during the quarter, reaching 11.4 million as of Sept. 30, 2025. Now, let’s look at how its bigger rivals have scored.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>T-Mobile US, Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TMUS\" target=\"_blank\">TMUS</a>) added 2.3 million <a href=\"https://www.benzinga.com/markets/earnings/25/10/48381282/t-mobile-raises-outlook-so-why-is-wall-street-selling\" rel=\"noreferrer noopener\" target=\"_blank\">postpaid customers in</a> the third quarter — its most substantial gain ever and the best in the industry. The company also added 1 million postpaid phone customers, its highest third-quarter increase in more than a decade. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>AT&amp;T Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/T\" target=\"_blank\">T</a>) added 405,000 postpaid phone customers, slightly up from 403,000 a year earlier. T-Mobile’s postpaid net account additions rose 26% year-over-year to 396,000, another record-setting and industry-leading result.</p><!--/$--><!--$--><p class=\"block core-block\">Charter’s adjusted EBITDA margin declined by 20 bps to 40.7%.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The quarterly free cash flow of $1.62 billion remained firm Y/Y, primarily driven by higher net cash flows from operating activities.</p><!--/$--><!--$--><p class=\"block core-block\">As of Sept. 30, Charter served 29.79 million residential and SMB Internet customers.</p><!--/$--><!--$--><p class=\"block core-block\">Net cash flow from operating activities totaled $4.5 billion during the quarter. As of Sept. 30, the company held $464 million in cash and equivalents.</p><!--/$--><!--$--><p class=\"block core-block\">Charter CEO <strong>Chris Winfrey</strong> stated that the company is operating well in a competitive environment.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>2025 Outlook:</strong> Charter Communications now expects capital expenditures (capex) of approximately $11.5 billion (down from the prior forecast of $12 billion) versus $11.3 billion <a href=\"https://www.benzinga.com/pressreleases/25/01/n43380977/charter-announces-fourth-quarter-and-full-year-2024-results\" rel=\"noreferrer noopener\" target=\"_blank\">in fiscal 2024</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>CHTR Price Action:</strong> Charter Communications shares were down 2.27% at $225.67 at the time of publication on Friday. The stock is trading near its 52-week low, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48561168\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/earnings/25/10/48537225/siriusxm-stock-jumps-10-after-raising-guidance-expanding-digital-ads-podcasting-growth\" rel=\"noreferrer noopener\" target=\"_blank\">SiriusXM Stock Jumps 10% After Raising Guidance, Expanding Digital Ads, Podcasting Growth</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image created using artificial intelligence via DALL-E.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/charter-dall-e.png",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48561168/charters-q3-miss-sends-stock-lower-as-internet-video-losses-pile-up",
            "pub_date": "2025-10-31 22:22:21",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904c242ecb8a7000146051f",
            "title": "20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>DexCom, Inc.’s </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/DXCM\" target=\"_blank\">DXCM</a>) third-quarter 2025 revenue reached $1.209 billion, beating the analyst consensus <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">estimate of $1.179 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue grew 22% year-over-year on a reported basis and 20% year-over-year on an organic basis.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">U.S. revenue grew 21% and international revenue grew 22% on a reported basis and 18% on an organic basis, all on a <a href=\"https://www.benzinga.com/pressreleases/25/10/b48543162/dexcom-reports-third-quarter-2025-financial-results-and-updates-full-year-2025-guidance\" rel=\"noreferrer noopener\" target=\"_blank\">year-over-year basis</a>.</p><!--/$--><!--$--><p class=\"block core-block\">GAAP operating income was $242.5 million or 20.1% of revenue, an increase of 480 basis points compared to the third quarter of 2024.</p><!--/$--><!--$--><p class=\"block core-block\">Adjusted operating income reached<strong></strong> $272.9 million or 22.6% of reported revenue, an increase of 130 basis points from a year ago.</p><!--/$--><!--$--><p class=\"block core-block\">DexCom reported adjusted earnings of 61 cents, beating the consensus of 57 cents.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/news/legal/25/10/48473230/dexcom-faces-new-reports-of-deaths-linked-to-g7-glucose-monitor\" rel=\"noreferrer noopener\" target=\"_blank\">DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor</a></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Outlook</strong>: On Thursday, DexCom raised fiscal 2025 sales guidance from $4.60 billion-$4.63 billion to $4.63 billion-$4.65 billion, above the consensus of $4.626 billion.</p><!--/$--><!--$--><p class=\"block core-block\">The company also revised its profit margins. It expects adjusted gross profit margin of approximately 61%, operating margin of approximately 20-21%, and EBITDA margin of roughly 29-30%, compared to <a href=\"https://www.benzinga.com/pressreleases/25/07/b46737069/dexcom-reports-second-quarter-2025-financial-results-updates-full-year-2025-guidance-and-announces\" rel=\"noreferrer noopener\" target=\"_blank\">previous guidance of approximately 62%</a>, approximately 62%, and approximately 30%, respectively.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Take</strong></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">William Blair, in a Friday investor note, wrote that the lower stock price is due to hopes for U.S. sales growth and 2026 commentary below the Street.</p><!--/$--><!--$--><p class=\"block core-block\">DexCom remains near record highs for new patient additions, and with minimal pricing pressure expected next year, sales growth could approach 20%.</p><!--/$--><!--$--><p class=\"block core-block\">William Blair also expects significant margin expansion as DexCom moves beyond scrap and freight cost headwinds and benefits from the upcoming 15-day sensor launch.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“Taken together, we are buyers on the weakness with shares at 24x times 2026 EPS with earnings positioned to grow 20%,” William Blair wrote.</p><!--/$--><!--$--><p class=\"block core-block\">BTIG analyst maintains a Buy rating on DexCom and lowers the <a href=\"https://www.benzinga.com/quote/DXCM/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">price forecast from $109 to $85</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: DXCM stock is down 11.28% to $60.51 in the premarket at the last check on Friday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/25/10/48555150/jim-cramer-tells-investors-to-avoid-usa-rare-earth-for-now\" rel=\"noreferrer noopener\" target=\"_blank\">Jim Cramer Tells Investors To Avoid USA Rare Earth — For Now</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48560265\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Dex-com--Inc.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48560265/20-earnings-growth-potential-for-dexcom-analyst-cites-buying-opportunity",
            "pub_date": "2025-10-31 22:05:58",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904c350ecb8a7000146064d",
            "title": "nVent Electric Boosts Outlook After First &#39;Billion-Dollar Quarter&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>nVent Electric plc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVT\" target=\"_blank\">NVT</a>), an electrical connection and protection solutions company, reported its <a href=\"https://s22.q4cdn.com/268397047/files/doc_financials/2025/q3/Q3-2025-NVT-Press-Release-FINAL.pdf\" rel=\"noreferrer noopener\" target=\"_blank\">third-quarter</a> results on Friday that topped street estimates.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings of 91 cents per share, up 44% from the prior year period, surpassing analysts’ expectations of 88 cents.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Net sales climbed to $1.05 billion, up 35% from a year earlier and ahead of estimates of $1.01 billion, while organic sales growth was 16% for the quarter. The company’s adjusted operating income rose 27% to $213 million.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/46835952/these-analysts-raise-their-forecasts-on-nvent-electric-after-strong-q2-earnings\" rel=\"noreferrer noopener\" target=\"_blank\">These Analysts Raise Their Forecasts On nVent Electric After Strong Q2 Earnings</a></em></strong></p><!--/$--><!--$--><p class=\"block core-block\">nVent’s free cash flow totaled $253 million, compared with $143 million in the same quarter of 2024. The company ended the quarter with cash and cash equivalents of $126.9 million.</p><!--/$--><!--$--><p class=\"block core-block\">The company’s board approved a regular quarterly cash dividend of 20 cents per share, payable on November 7, 2025.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><p class=\"block core-block\">Sales in the Systems Protection segment increased to $716 million from $477 million in the prior year, representing a 50% increase, while organic sales also increased by 23%.</p><!--/$--><!--$--><p class=\"block core-block\">The Electrical Connections segment reported sales of $338 million, up 11% from $305 million in the same period last year, with organic sales growth of 5%.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">nVent Electric raised its full-year 2025 outlook, now expecting reported sales growth of 27% to 28%, up from its prior guidance of 24% to 26%.</p><!--/$--><!--$--><p class=\"block core-block\">The company also projects adjusted earnings per share of $3.31 to $3.33, compared with the earlier range of $3.22 to $3.30. Wall Street analysts anticipate earnings of $3.29 per share from sales of $3.76 billion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">For the fourth quarter, nVent anticipates reported sales growth of 31% to 33% and organic sales growth of 15% to 17%, with an adjusted EPS forecast of between 87 cents and 89 cents. In contrast, Wall Street analysts expect an adjusted EPS of 88 cents.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>CEO Commentary</strong></h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Beth Wozniak</strong>, nVent chair and chief executive officer, stated, “This was our first billion-dollar sales quarter, and we had record orders, backlog and strong cash flow. We also launched a number of new products, expanded capacity in several facilities to support data center and power utility growth, and executed on our acquisition integration playbook.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“Our portfolio transformation is driving success, and we are raising our full-year sales and EPS guidance to reflect our record third quarter performance and our significant momentum in data centers. I want to recognize the hard work and dedication of our nVent team to deliver these outstanding results,” he added.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: NVT shares were trading higher by 10.68% to $115.49 at last check Friday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48560560\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48555675/western-digital-analysts-boost-their-forecasts-after-better-than-expected-q1-results\" rel=\"noreferrer noopener\" target=\"_blank\">Western Digital Analysts Boost Their Forecasts After Better-Than-Expected Q1 Results</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by T. Schneider via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Stuttgart--Germany---12-09-2024-Person-H.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48560560/nvent-electric-boosts-outlook-after-first-billion-dollar-quarter",
            "pub_date": "2025-10-31 22:10:28",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904a395ecb8a7000145effe",
            "title": "Top 2 Health Care Stocks That May Fall Off A Cliff This Quarter",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">As of Oct. 31, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p><!--/$--><!--$--><p class=\"block core-block\">The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href=\"https://www.benzinga.com/topic/rsi\" target=\"_blank\">RSI is above 70</a>, according to <a href=\"https://pro.benzinga.com/\" target=\"_blank\">Benzinga Pro</a>. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Here's the latest list of major overbought players in this sector.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\"><strong>Alphatec Holdings Inc (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ATEC\" target=\"_blank\">ATEC</a>)</strong></h3><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>On Oct. 30, Alphatec Holdings reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates. “I’m eXtremely proud of the entire ATEC team for delivering another quarter of industry-leading results,” said Pat Miles, Chairman and Chief Executive Officer. The company's stock gained around 12% over the past month and has a 52-week high of $17.14.</li>\n<li><strong>RSI Value:</strong> 82.5                                </li>\n<li><strong>ATEC Price Action:</strong> Shares of Alphatec fell 1% to close at $16.33 on Thursday.</li>\n<li>Edge Stock Ratings: 91.00 Momentum score.</li>\n</ul><!--/$--><!--$--><!--/$--><!--$--><h3 class=\"wp-block-heading\"><strong>Travere Therapeutics Inc (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TVTX\" target=\"_blank\">TVTX</a>)</strong></h3><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>On Oct. 30, Travere Therapeutics reported better-than-expected third-quarter sales results. “We delivered outstanding commercial performance in the third quarter, reflecting the growing role of FILSPARI as a foundational therapy in IgAN. This success underscores the strength of our commercial execution and the expanding confidence in FILSPARI among physicians and patients,” said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. The company's stock gained around 24% over the past month and<a href=\"https://www.benzinga.com/quote/TVTX\" target=\"_blank\"> has a 52-week high</a> of $30.97.</li>\n<li><strong>RSI Value:</strong> 80.9</li>\n<li><strong>TVTX Price Action:</strong> Shares of Travere Therapeutics fell 1.1% to close at $29.65 on Thursday.    </li>\n</ul><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">How do other stocks rank? Get the full <a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" target=\"_blank\">BZ Edge Rankings breakdown here</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read This Next: </strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48524289/jim-cramer-likes-toast-but-isnt-buying-shares-yet\" target=\"_blank\">Jim Cramer Likes Toast, But Isn’t Buying Shares—Yet</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48555015\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Healthcare-Funding-Pressure.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/short-ideas/25/10/48555015/top-2-health-care-stocks-that-may-fall-off-a-cliff-this-quarter",
            "pub_date": "2025-10-31 19:55:05",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}